The market for Needle-Free Injectors was valued at US$ 6.1 billion in 2021 and is anticipated to grow at a CAGR of 15.5% by 2032.The increasing frequency of communicable diseases brought on by needle-stick injuries, the market growth for biosimilars and immunization, the benefits of drug delivery applications, and t...